Jensen Mark S, Hoerrner R Scott, Li Wenjie, Nelson Dorian P, Javadi Gary J, Dormer Peter G, Cai Dongwei, Larsen Robert D
Department of Process Research, Merck Research Laboratories, P.O. Box 2000, Rahway, NJ 07065, USA.
J Org Chem. 2005 Jul 22;70(15):6034-9. doi: 10.1021/jo050741o.
A practical synthesis of 2-[3-(4-fluoro-3-pyridin-3-yl-phenyl)-imidazo[1,2-a]pyrimidin-7-yl]-propan-2-ol (1), an oral GABA(A) alpha(2/3)-selective agonist, is described. The five-step process, which afforded 1 in 40% overall yield, included imidazopyrimidine 2 and pyridine boronic acid 4 as key fragments. The synthesis is highlighted by consecutive Pd-catalyzed coupling steps to assemble the final free base 1 in high yield and regioselectivity. A novel method for Pd removal in the final step is also described.
描述了2-[3-(4-氟-3-吡啶-3-基苯基)-咪唑并[1,2-a]嘧啶-7-基]-丙-2-醇(1)的实用合成方法,1是一种口服的GABA(A)α(2/3)选择性激动剂。该五步反应总产率为40%,其中咪唑并嘧啶2和吡啶硼酸4为关键片段。该合成方法的亮点在于通过连续的钯催化偶联步骤以高收率和区域选择性组装得到最终的游离碱1。还描述了最后一步中去除钯的新方法。